Abeona Therapeutics Inc.
ABEO· Nasdaq
Abeona Therapeutics Inc.
- Last sale
- Oct 2, 2026 · +0.80%
- Market cap
- $288.21M
- 57.18M shares
- Filings
- 1,026
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $5,820,000 | reported | |
| FY 2023 | 2023-12-31 | $3,500,000 | reported | |
| FY 2022 | 2022-12-31 | $1,414,000 | reported | |
| FY 2021 | 2021-12-31 | $3,000,000 | reported | |
| FY 2020 | 2020-12-31 | $10,000,000 | reported | |
| FY 2018 | 2018-12-31 | $2,998,000 | reported | |
| FY 2017 | 2017-12-31 | $837,000 | reported | |
| FY 2016 | 2016-12-31 | $889,000 | reported | |
| FY 2015 | 2015-12-31 | $1,040,000 | reported | |
| FY 2014 | 2014-12-31 | $925,000 | reported | |
| FY 2013 | 2013-12-31 | $2,042,000 | reported | |
| FY 2012 | 2012-12-31 | $4,404,000 | reported |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
